{
    "Disease activity (follow up: 1 year; assessed with: ACR 20)": {
      "No of studies": ["1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "a"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious","b"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "11/31 (35.5%)",
        "Switch to a 2nd TNFi": "17/31 (54.8%)"
      },
      "Effect": {
        "Relative (95% CI)": "RR 0.65 (0.37 to 1.15)",
        "Absolute (95% CI)": "192 fewer per 1,000 (from 345 fewer to 82 more)"
      },
      "Certainty": "very low",
      "Importance": "critical"
    },
    "Disease activity (follow up: 1 year; assessed with: ACR 50)": {
      "No of studies": ["1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "a"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious","b"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "6/32 (18.8%)",
        "Switch to a 2nd TNFi": "9/31 (29.0%)"
      },
      "Effect": {
        "Relative (95% CI)": "RR 0.65 (0.26 to 1.60)",
        "Absolute (95% CI)": "102 fewer per 1,000 (from 215 fewer to 174 more)"
      },
      "Certainty": "very low",
      "Importance": "critical"
    },
    "Disease activity (follow up: 1 year; assessed with: ACR 70)": {
      "No of studies": ["1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "a"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious","b"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "3/32 (9.4%)",
        "Switch to a 2nd TNFi": "5/31 (16.1%)"
      },
      "Effect": {
        "Relative (95% CI)": "RR 0.58 (0.15 to 2.23)",
        "Absolute (95% CI)": "68 fewer per 1,000 (from 137 fewer to 198 more)"
      },
      "Certainty": "very low",
      "Importance": "critical"
    },
    "Remission (follow up: 1 year; assessed with: DAS28-ESR <2.6)": {
      "No of studies": ["2","1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "c"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["serious", "d"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "6/76 (7.9%)",
        "Switch to a 2nd TNFi": "17/80 (21.3%)"
      },
      "Effect": {
        "Relative (95% CI)": "RR 0.38 (0.16 to 0.91)",
        "Absolute (95% CI)": "132 fewer per 1,000 (from 179 fewer to 19 fewer)"
      },
      "Certainty": "low",
      "Importance": "critical"
    },
    "Disease activity (follow up: 1 year; assessed with: DAS28-ESR (MCID -1.17))": {
      "No of studies": ["2","1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "c"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["serious", "e"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "76",
        "Switch to a 2nd TNFi": "80"
      },
      "Effect": {
        "Relative (95% CI)": "-",
        "Absolute (95% CI)": "MD 0.45 higher (0.02 higher to 0.88 higher)"
      },
      "Certainty": "low",
      "Importance": "critical"
    },
    "Disability (follow up: 1 year; assessed with: HAQ-DI (MCID -0.22))": {
      "No of studies": ["2","1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "c"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious","f"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "77",
        "Switch to a 2nd TNFi": "81"
      },
      "Effect": {
        "Relative (95% CI)": "-",
        "Absolute (95% CI)": "MD 0.04 higher (0.17 lower to 0.25 higher)"
      },
      "Certainty": "very low",
      "Importance": "important"
    },
    "Quality of life (follow up: 1 year; assessed with: RAQol (MCID 2))": {
      "No of studies": ["1"],
      "Study design": "randomised trials",
      "Risk of bias": ["serious", "a"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious","b"],
      "Other considerations": "none",
      "No of patients": {
        "Switch to ABA": "34",
        "Switch to a 2nd TNFi": "30"
      },
      "Effect": {
        "Relative (95% CI)": "-",
        "Absolute (95% CI)": "MD 1.5 lower (6.36 lower to 3.36 higher)"
      },
      "Certainty": "very low",
      "Importance": "important"
    },
    "Pain (follow up: 1 year; assessed with: VAS 0-100 (MCID -11.9))": {
        "No of studies": ["1"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","b"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "34",
          "Switch to a 2nd TNFi": "31"
        },
        "Effect": {
          "Relative (95% CI)": "-",
          "Absolute (95% CI)": "MD 2.5 higher (14.99 lower to 19.99 higher)"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Serious adverse events (follow up: 1 year)": {
        "No of studies": ["2","1"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "c"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","g"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "5/63 (7.9%)",
          "Switch to a 2nd TNFi": "1/65 (1.5%)"
        },
        "Effect": {
          "Relative (95% CI)": "RR 3.75 (0.64 to 22.11)",
          "Absolute (95% CI)": "42 more per 1,000 (from 6 fewer to 325 more)"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Withdrawal due to lack of efficacy (follow up: 1 year)": {
        "No of studies": ["1"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","b"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "3/41 (7.3%)",
          "Switch to a 2nd TNFi": "2/41 (4.9%)"
        },
        "Effect": {
          "Relative (95% CI)": "RR 1.50 (0.26 to 8.51)",
          "Absolute (95% CI)": "24 more per 1,000 (from 36 fewer to 366 more)"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Withdrawal due to adverse events (follow up: 1 year)": {
        "No of studies": ["1"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","d"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "1/41 (2.4%)",
          "Switch to a 2nd TNFi": "0/41 (0.0%)"
        },
        "Effect": {
          "Relative (95% CI)": "RR 3.00 (0.13 to 71.56)",
          "Absolute (95% CI)": "0 fewer per 1,000 (from 0 fewer to 0 fewer)"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Malignancy (follow up: 1 year)": {
        "No of studies": ["2"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "c"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "d"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "0/22 (0.0%)",
          "Switch to a 2nd TNFi": "0/24 (0.0%)"
        },
        "Effect": {
          "Relative (95% CI)": "Not estimable",
          "Absolute (95% CI)": "Not estimable"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Cardiovascular disease (follow up: 1 year)": {
        "No of studies": ["2"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "c"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","b"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "1/22 (4.5%)",
          "Switch to a 2nd TNFi": "2/24 (8.3%)"
        },
        "Effect": {
          "Relative (95% CI)": "RR 0.55 (0.05 to 5.60)",
          "Absolute (95% CI)": "37 fewer per 1,000 (from 79 fewer to 383 more)"
        },
        "Certainty": "very low",
        "Importance": "important"
      },
      "Death (follow up: 1 year)": {
        "No of studies": ["1"],
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "c"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious","b"],
        "Other considerations": "none",
        "No of patients": {
          "Switch to ABA": "1/41 (2.4%)",
          "Switch to a 2nd TNFi": "0/41 (0.0%)"
        },
        "Effect": {
          "Relative (95% CI)": "RR 3.00 (0.13 to 71.56)",
          "Absolute (95% CI)": "0 fewer per 1,000 (from 0 fewer to 0 fewer)"
        },
        "Certainty": "very low",
        "Importance": "important"
      }
  }
  